NINDS Neuroscience Funding Announcements

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.

---

Parkinson's Disease Neuroprotection Clinical Trial: Clinical Centers
Release Date: July 2, 2001
Announcement Number: RFA-NS-02-010
Application Receipt Date:
November 15, 2001   
Letter of Intent Date: September 15, 2001

Funding Contact: NINDS Funding
Program Area: Neurodegeneration, Office of Clinical Research

Brief Description:
The Neurodegeneration and Clinical Trial Groups of the National Institute of Neurological Disorders and Stroke (NINDS) request applications for clinical centers to collaborate in the performance of a large, double-blind randomized trial of two or more potential neuroprotective agents in patients early in the course of Parkinson’s disease. Applications for coordinating and statistical centers were requested in a separate solicitation (http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-01-012.html). The trial was called for in the NIH Parkinson Research Agenda (http://www.ninds.nih.gov/about_ninds/nihparkinsons_agenda.htm). The neuroprotectants to be tested in the trial have not yet been chosen and will be selected by an NINDS-appointed Oversight Committee from among those proposed by the applicants who respond to this Request for Applications (RFA) as well as from those suggested by others, including NINDS grantees, pharmaceutical companies, patients, and patient advocates.

Choose an option to view additional funding announcements

New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives